Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
- PMID: 29559851
- PMCID: PMC5859479
- DOI: 10.7150/ijbs.23247
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Abstract
Neurodegenerative diseases are conventionally demarcated as disorders with selective loss of neurons. Conventional as well as newer molecules have been tested but they offer just symptomatic advantages along with abundant side effects. The discovery of more compelling molecules that can halt the pathology of these diseases will be considered as a miracle of present time. Several synthetic compounds are available but they may cause several other health issues. Therefore, natural molecules from the plants and other sources are being discovered to replace available medicines. In conventional medicational therapies, several plants have been reported to bestow remedial effects. Phytochemicals from medicinal plants can provide a better and safer alternative to synthetic molecules. Many phytochemicals have been identified that cure the human body from a number of diseases. The present article reviews the potential efficacy of plant-derived alkaloids, which possess potential therapeutic effects against several NDDs including Alzheimer's disease (AD), Huntington disease (HD), Parkinson's disease (PD), Epilepsy, Schizophrenia, and stroke. Alkaloids include isoquinoline, indole, pyrroloindole, oxindole, piperidine, pyridine, aporphine, vinca, β-carboline, methylxanthene, lycopodium, and erythrine byproducts. Alkaloids constitute positive roles in ameliorating pathophysiology of these illnesses by functioning as muscarinic and adenosine receptors agonists, anti-oxidant, anti-amyloid and MAO inhibitors, acetylcholinestrase and butyrylcholinesterase inhibitor, inhibitor of α-synuclein aggregation, dopaminergic and nicotine agonist, and NMDA antagonist.
Keywords: Neurodegenerative diseases; Phytochemicals; Plant derived alkaloids; acetylcholinestrase; butyrylcholinesterase; monoamine oxidase..
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures



Similar articles
-
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship.CNS Neurol Disord Drug Targets. 2023;22(7):1057-1069. doi: 10.2174/1871527321666220614110616. CNS Neurol Disord Drug Targets. 2023. PMID: 35702799 Review.
-
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.Phytomedicine. 2023 Apr;112:154686. doi: 10.1016/j.phymed.2023.154686. Epub 2023 Jan 31. Phytomedicine. 2023. PMID: 36804755 Review.
-
Alkaloids Pharmacological Activities - Prospects for the Development of Phytopharmaceuticals for Neurodegenerative Diseases.Curr Pharm Biotechnol. 2016;17(7):629-35. doi: 10.2174/138920101707160503201541. Curr Pharm Biotechnol. 2016. PMID: 26718919 Review.
-
Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease.Molecules. 2023 Nov 14;28(22):7588. doi: 10.3390/molecules28227588. Molecules. 2023. PMID: 38005310 Free PMC article. Review.
-
Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.Molecules. 2022 May 18;27(10):3222. doi: 10.3390/molecules27103222. Molecules. 2022. PMID: 35630702 Free PMC article. Review.
Cited by
-
Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids.Front Pharmacol. 2022 Mar 22;13:668065. doi: 10.3389/fphar.2022.668065. eCollection 2022. Front Pharmacol. 2022. PMID: 35392565 Free PMC article.
-
Protective effects of Vinca herbaceous extract against scopolamine-induced behavioral disturbances and brain oxidative stress in rats.Heliyon. 2022 Apr 19;8(4):e09295. doi: 10.1016/j.heliyon.2022.e09295. eCollection 2022 Apr. Heliyon. 2022. PMID: 35520614 Free PMC article.
-
Potential Therapeutic Applications of Plant-Derived Alkaloids against Inflammatory and Neurodegenerative Diseases.Evid Based Complement Alternat Med. 2022 Mar 9;2022:7299778. doi: 10.1155/2022/7299778. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35310033 Free PMC article. Review.
-
Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases.J Mol Neurosci. 2022 Mar;72(3):653-676. doi: 10.1007/s12031-021-01922-7. Epub 2021 Oct 25. J Mol Neurosci. 2022. PMID: 34697770 Review.
-
Strychnos nux-vomica L. seed preparation promotes functional recovery and attenuates oxidative stress in a mouse model of sciatic nerve crush injury.BMC Complement Med Ther. 2020 Jun 11;20(1):181. doi: 10.1186/s12906-020-02950-3. BMC Complement Med Ther. 2020. PMID: 32527244 Free PMC article.
References
-
- Kovacs GG. CURRENT CONCEPTS OF NEURODEGENERATIVE DISEASES. Cit EMJ Neurol. 2014;1(July):78–86.
-
- Hussain G, Shahzad A, Anwar H, Sohail MU, Baig SM, Shabbir A, Neurological disorder burden in Faisalabad, Punjab-Pakistan: data from the major tertiary care centers of the city. Pakistan J Neurol Sci; 2017. p. 12. (3)
-
- Kumar Gp, Khanum F. Neuroprotective potential of phytochemicals. Pharmacogn Rev [Internet] 2012;6(12):81.. Available from: http://www.phcogrev.com/text.asp?2012/6/12/81/99898. - PMC - PubMed
-
- Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F. et al. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One [Internet] 2013;8(6):e64525.. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3681796&tool=p.... - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical